Director, Translational Imaging & Biomarkers

BlueRock Therapeutics LP; Cambridge (MA); On-site; USD 203,000 - 215,000; Full time

Job summary

BlueRock Therapeutics, a Bayer-backed company, is seeking a Director of Imaging and Biomarkers, Translational Medicine, based in Cambridge, MA. You will lead translational imaging strategies, drive biomarker development, and partner with cross-functional teams to advance CNS, ophthalmic, and inflammatory programs.

The role requires a PhD/MD/PharmD or equivalent with 6+ years in translational imaging and clinical development, plus deep MRI/PET expertise and experience in imaging core labs and CRO

Qualifications

• PhD/MD/PharmD or equivalent in Neuroscience, Biomedical Imaging, Radiology or related field.
• 6+ years in translational medicine, imaging sciences or clinical development.
• Deep expertise in clinical and translational neuroimaging (MRI and PET).
• Direct experience managing imaging protocols in clinical trials.

Responsibilities

• Develop translational imaging strategies to support clinical plans and regulatory paths.
• Lead translational imaging strategies for proof-of-mechanism and patient stratification.
• Serve as neuroimaging lead on cross-functional program teams.
• Partner with Research to characterize novel imaging biomarkers in preclinical studies.
• Develop and validate imaging methods for clinical use.
• Implement biomarker strategies to drive decision-making across stages of development.
• Lead imaging governance and expert activities (MRI, PET, SPECT, HRCT).
• Oversee CROs and vendors for imaging projects in the US, Canada, and others.

Skills

Translational imaging

MRI

PET

Clinical development

Neuroimaging

Imaging core lab

CRO management

Education

PhD, MD, PharmD or equivalent

Job description

BlueRock Therapeutics, a Bayer-backed company, is seeking a Director of Imaging and Biomarkers, Translational Medicine, based in Cambridge, MA. You will lead translational imaging strategies, drive biomarker development, and partner with cross-functional teams to advance CNS, ophthalmic, and inflammatory programs.

The role requires a PhD/MD/PharmD or equivalent with 6+ years in translational imaging and clinical development, plus deep MRI/PET expertise and experience in imaging core labs and CRO